MYDGF as a telomerase activator and therapeutic target for osteoarthritis

Yijun He , Chujun Li , Kexin Chen , Xining Wang , Shengxin Xu , Zhifen Zhou , Li Yin , Jialu Zheng , Yifan Wu , Wenbin Ma , Zhou Songyang , Yan Huang

Advanced Biotechnology ›› 2026, Vol. 4 ›› Issue (3) : 34

PDF
Advanced Biotechnology ›› 2026, Vol. 4 ›› Issue (3) :34 DOI: 10.1007/s44307-026-00119-6
Article
research-article
MYDGF as a telomerase activator and therapeutic target for osteoarthritis
Author information +
History +
PDF

Abstract

Osteoarthritis (OA) involves progressive cartilage breakdown. This is driven by impaired chondrocyte function and an imbalance in the extracellular matrix homeostasis. However, the key upstream regulators that maintain healthy chondrocytes are still not fully known. Here, we report that myeloid-derived growth factor (MYDGF) is a novel regulator of telomerase activity and is critical for cartilage health. Using a genome-wide CRISPR-Cas9 screen with a TERT reporter system, MYDGF was identified as a strong positive regulator of telomerase. Functional studies confirmed that MYDGF positively regulates TERT expression and telomerase activity in both HeLa and ATDC5 cells. In a mouse surgical destabilization of the medial meniscus (DMM) OA model, MYDGF knockout (KO) mice exhibited more severe cartilage damage. Conversely, delivering MYDGF into the knee joint using AAV virus partially alleviated cartilage injury. Transcriptome profiling revealed that MYDGF-deficient chondrocytes exhibit downregulated key pathways involved in matrix building and upregulated inflammatory signals, indicating a shift in cell state. In summary, our work establishes MYDGF as a key upstream factor for both telomerase and cartilage matrix homeostasis remodeling. It connects telomerase function to chondrocyte health. These findings also highlight MYDGF as a promising new target for treating osteoarthritis.

Keywords

Osteoarthritis (OA) / Cartilage degeneration / Myeloid-derived growth factor (MYDGF) / Telomerase

Cite this article

Download citation ▾
Yijun He, Chujun Li, Kexin Chen, Xining Wang, Shengxin Xu, Zhifen Zhou, Li Yin, Jialu Zheng, Yifan Wu, Wenbin Ma, Zhou Songyang, Yan Huang. MYDGF as a telomerase activator and therapeutic target for osteoarthritis. Advanced Biotechnology, 2026, 4 (3) : 34 DOI:10.1007/s44307-026-00119-6

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Armanios M, Alder JK, et al.. Short telomeres are sufficient to cause the degenerative defects associated with aging. Am J Hum Genet, 2009, 85(6823-832

[2]

Bortnov V, Tonelli M, et al.. Solution structure of human myeloid-derived growth factor suggests a conserved function in the endoplasmic reticulum. Nat Commun, 2019, 10(1): 5612

[3]

Childs BG, Durik M, et al.. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med, 2015, 21(12): 1424-1435

[4]

Diffendall GM, Resendes KK. The effect of increased intracellular calcium on the localization of the catabolic subunit of telomerase, hTERT, in HeLa cells. J Stud Res, 2015, 4(1): 99-103

[5]

He M, Li Y, et al.. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease. Diabetologia, 2020, 63(9): 1916-1931

[6]

Iwasa K, Hayashi S, et al.. PTEN regulates matrix synthesis in adult human chondrocytes under oxidative stress. J Orthop Res, 2014, 32(2): 231-237

[7]

Korf-Klingebiel M, Reboll MR, et al.. Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction. Nat Med, 2015, 21(2): 140-149

[8]

Kroemer G, Maier AB, et al.. From geroscience to precision geromedicine: understanding and managing aging. Cell, 2025, 188(8): 2043-2062

[9]

Liu C, Lin K, et al.. Telomerase reverse transcriptase regulates intracellular Ca(2+) homeostasis and mitochondrial function via the p53/PGC-1α pathway in HL-1 cells. Front Biosci (Landmark Ed), 2024, 29(7): 263

[10]

López-Otín C, Blasco MA, et al.. The hallmarks of aging. Cell, 2013, 153(6): 1194-1217

[11]

López-Otín C, Blasco MA, et al.. Hallmarks of aging: an expanding universe. Cell, 2023, 186(2): 243-278

[12]

Maciejowski J, de Lange T. Author correction: telomeres in cancer: tumour suppression and genome instability. Nat Rev Mol Cell Biol, 2019, 20(4): 259

[13]

Martin JA, Buckwalter JA. Aging, articular cartilage chondrocyte senescence and osteoarthritis. Biogerontology, 2002, 3(5): 257-264

[14]

Meng B, Li Y, et al.. Myeloid-derived growth factor inhibits inflammation and alleviates endothelial injury and atherosclerosis in mice. Sci Adv, 2021, 7(21 eabe6903

[15]

Miwa S, Czapiewski R, et al.. Decreased mTOR signalling reduces mitochondrial ROS in brain via accumulation of the telomerase protein TERT within mitochondria. Aging (Albany NY), 2016, 8(10): 2551-2567

[16]

Muñoz-Lorente MA, Cano-Martín AC, et al.. Mice with hyper-long telomeres show less metabolic aging and longer lifespans. Nat Commun, 2019, 10(1): 4723

[17]

Passos JF, Nelson G, et al.. Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol Syst Biol, 2010, 6 347

[18]

Price JS, Waters JG, et al.. The role of chondrocyte senescence in osteoarthritis. Aging Cell, 2002, 1(1): 57-65

[19]

Roach HI, Yamada N, et al.. Association between the abnormal expression of matrix degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum, 2005, 52(10): 3110-3124

[20]

Rosenberger S, Thorey IS, et al. A novel regulator of telomerase. S100A8 mediates differentiation-dependent and calcium-induced inhibition of telomerase activity in the human epidermal keratinocyte line HaCaT. J Biol Chem. 2007;282(9):6126–6135.

[21]

Rossiello F, Jurk D, et al.. Telomere dysfunction in ageing and age-related diseases. Nat Cell Biol, 2022, 24(2): 135-147

[22]

Shay JW, Wright WE. Telomeres and telomerase: three decades of progress. Nat Rev Genet, 2019, 20(5): 299-309

[23]

Stanic I, Facchini A, et al.. Polyamine depletion inhibits apoptosis following blocking of survival pathways in human chondrocytes stimulated by tumor necrosis factor-alpha. J Cell Physiol, 2006, 206(1): 138-146

[24]

Sunagozaka H, Honda M, et al.. Identification of a secretory protein c19orf10 activated in hepatocellular carcinoma. Int J Cancer, 2011, 129(7): 1576-1585

[25]

Tulin EE, Onoda N, et al.. SF20/IL-25, a novel bone marrow stroma-derived growth factor that binds to mouse thymic shared antigen-1 and supports lymphoid cell proliferation. J Immunol, 2003, 170(3): 1593

[26]

Wang P, Mariman E, et al.. Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines. Cell Mol Life Sci, 2004, 61(18): 2405-2417

[27]

Wang Y, Li Y, et al.. MYDGF promotes cardiomyocyte proliferation and neonatal heart regeneration. Theranostics, 2020, 10(20): 9100-9112

[28]

Weiler S, Bellmann R. Posaconazole prophylaxis in hematologic cancer. N Engl J Med, 2007, 356(21): 2214-2218

[29]

Wilson AC, Chiles J, et al.. Integrated bioinformatics analysis identifies established and novel TGFβ1-regulated genes modulated by anti-fibrotic drugs. Sci Rep, 2022, 12(1 3080

[30]

Zhang Q, Lai S, et al.. Protective effects of PI3K/Akt signal pathway induced cell autophagy in rat knee joint cartilage injury. Am J Transl Res, 2018, 10(3): 762-770

[31]

Zhou Z, Li Y, et al.. An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. iScience, 2022, 25(2 103813

Funding

National Natural Science Foundation of China(82271598)

Rights & permissions

The Author(s)

PDF

7

Accesses

0

Citation

Detail

Sections
Recommended

/